60. Aplastic anemia Clinical trials / Disease details

Clinical trials : 245 /  Drugs : 318 - (DrugBank : 86) / Drug target genes : 44 - Drug target pathways : 166

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1ChiCTR2000041485
2021-01-012020-12-27Efficacy of Danazol after no response to cyclosporin in transfusion independent aplastic anemia: a prospective studyEfficacy of Danazol after no response to cyclosporin in transfusion independent aplastic anemia: a prospective study transfusion independent aplastic anemiaexperimental group:Cyclosporine combined with danazol;control group:Cyclosporine;Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical CollegeNULLRecruitingBothexperimental group:152;control group:76;Phase 4China
2NCT01441037
(ClinicalTrials.gov)		July 19, 201124/9/2011Danazol for Genetic Bone Marrow and Lung DisordersMale Hormones for Telomere Related DiseasesAplastic AnemiaDrug: DanazolNational Heart, Lung, and Blood Institute (NHLBI)NULLCompleted2 YearsN/AAll27Phase 1/Phase 2United States